Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Influenza Test Evaluated for Children

By LabMedica International staff writers
Posted on 24 May 2011
A rapid influenza assay has been evaluated for use with elementary school children and compared with a molecular test. More...


The test is a lateral-flow immunoassay that uses monoclonal antibodies specific for influenza viral nucleoprotein antigens and detects and differentiates between influenza A and B.

Public Health specialists at the University of Pittsburgh, (Pittsburgh, PA, USA), collected 278 pairs of nasal swabs from children during home visits during the 2007-2008 influenza season. One swab was tested with the immunoassay, which takes 10 minutes or less, and the other with a real time, reverse transcriptase polymerase chain reaction (RT-PCR). A total of 104 samples were positive by RT-PCR test, and of these, 54/104 (52%) were influenza A and 50/104 (48%) were influenza B.

Only 28/104 (27%), of these influenza-positive samples were detected as positive by QuickVue rapid immunoassay influenza testing. Influenza A accounted for 17 (61%) of the 28 positive tests, and of the remaining 11 (39%) were influenza B. The sensitivity and specificity of rapid influenza testing, using the QuickVue Influenza A+B test (Quidel; San Diego, CA, USA), in the students with influenza like illness who were tested was 27% (28/104) and 97% (168/174), respectively. The overall positive predictive value was 82% (28/34) and 69% (168/244) for negative predictive values. There was no statistically valid correlation between the semiquantitative PCR result and the QuickVue result.

The authors concluded that community testing includes patients who represent the entire spectrum of illness, with the majority exhibiting mild to moderate symptoms and not requiring medical attention. Viral load, technique, and the use of nasal swabs were examined as contributing factors to the low sensitivity of the QuickVue test, but were not found to be explanations for this result. If tests with higher sensitivities in community settings were available, they could be used as a part of an improved surveillance and early warning system for influenza activity and rapid confirmation of outbreaks. The study was published in March 2011, in the journal Influenza and Other Respiratory Viruses.

Related Links:

University of Pittsburgh
Quidel




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.